Biotech entity
All 1 tracked stories fall under one category: pharma. Copper-64 is most often covered alongside Clarity Pharmaceuticals, which appears in 1 of these 1 story. Copper-64 appears in 1 tracked Biotech story from March 25, 2026. The tracked stories average 2 original sources each.
Last mentioned: Mar 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Copper-64 is most often covered alongside Clarity Pharmaceuticals, which appears in 1 of these 1 story. Copper-64 appears in 1 tracked Biotech story from March 25, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Copper-64. Shared-story counts are live from our verified record — not editorial picks.
Clarity Pharmaceuticals has signed a major manufacturing supply agreement with Theragenics to secure large-scale production of copper-64. This partnership bolsters the supply chain for Clarity’s Targeted Copper Theranostics platform as it moves toward late-stage clinical trials.
Copper-64 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
